Metabolic Approaches to Chronic Liver Disease (L2)
March 1-4, 2027  | Keystone Resort, Keystone, CO, United States
Jay D. Horton, Bei B. Zhang and Samuel Klein
Scholarship Deadline: Nov. 5, 2026 | Abstract Deadline: Feb. 10, 2027 | Early Registration Deadline: Dec. 31, 2026
* Session Chair † Invited but not yet accepted | Program current as of November 16, 2026 2 AM | For the most up-to-date details, visit https://www.keystonesymposia.org
Monday, March 1, 2027
4:00–8:00 PM Registration Longs Peak Foyer
6:00–8:00 PM Welcome Mixer Longs Peak Foyer
Tuesday, March 2, 2027
7:00–8:00 AM Breakfast Quandary Peak
8:00–8:10 AM Welcome Remarks Grays Peak
8:10–9:00 AM Keynote Address Grays Peak
  Helen H. Hobbs, University of Texas Southwestern Medical Center
Genetic Determinants of Chronic Liver Disease Progression
 
9:00–11:30 AM Role of Intrahepatic Lipid Metabolism in Steatotic Liver Diseases Grays Peak
  Jay D. Horton, University of Texas Southwestern Medical Center
Role of Intrahepatic Lipid Metabolism in Steatotic Liver Diseases
 
  Peter A. Crawford, Baylor College of Medicine
Ketogenesis and Fatty Acid Synthesis
 
  Kathryn E. Wellen, University of Pennsylvania
New and Surprising Directions in de novo Lipogenesis
 
  Brian N. Finck, Washington University
From Energy to Remedy: Targeting Mitochondrial Metabolism
 
9:30–9:50 AM Coffee Break Longs Peak Foyer
11:40–12:25 PM Panel Discussion 1: What will be the Residual Risk if Patients are Placed in Incretin Therapy for Obesity? Then, What is the Residual Risk in MASH? Grays Peak
12:25–1:00 PM Poster Setup Quandary Peak
12:25–2:30 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Quandary Peak
2:30–4:30 PM Symposia Spotlight 1 Grays Peak
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM Molecular Drivers of Chronic Liver Disease Grays Peak
  Ana Maria Cuervo, Albert Einstein College of Medicine
Role of Autophagy in Chronic Liver Disease
 
  Shuang Wang, Mount Sinai
Role of Endothelium in MASH Progression and Regression
 
  Orian S Shirihai, David Geffen School of Medicine at UCLA
Mitochondrial Function in Chronic Liver Disease
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner Quandary Peak
7:30–10:00 PM Poster Session 1 Quandary Peak
Wednesday, March 3, 2027
7:00–8:00 AM Breakfast Quandary Peak
8:00–11:00 AM Emerging Therapeutic Approaches to Treat Chronic Liver Diseases Grays Peak
  Bei B. Zhang, Novo Nordisk
Unraveling Complex Biology and Improving Cardiometabolic Health with New Therapies
 
  Erik Ingelsson, Wave Life Sciences
Unlocking the Potential of RNA Medicines for Metabolic and Hepatic Disorders
 
  Katrin J. Svensson, Stanford University
Role of Non-Incretin Peptides in Obesity and MASLD
 
  Gerald I Shulman, Yale School of Medicine
Targeting Hepatic Mitochondria: Liver-Directed Protonophores for the Treatment of MASLD and MASH
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:00–1:00 PM Poster Setup Quandary Peak
11:10–12:10 PM Panel Discussion 2: Is Weight Loss Induced Loss in Muscle Mass a Problem? Grays Peak
12:10–3:00 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Quandary Peak
3:00–4:30 PM Career Roundtable Longs Peak
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM Peripheral Organ Contribution and Pathogenesis of Liver Fibrosis Grays Peak
  David A Brenner, Sanford Burnham Prebys
Molecular Events Leading to Stellate Cell Activation and Fibrosis in Chronic Liver Disease
 
  Timo D Müller, Helmholtz Munich
Improving Liver Health using Next Generation Incretin-Based Polyagonists
 
  Liming Pei, Children's Hospital of Philadelphia/University of Pennsylvania
Pathogenesis and Mechanisms Underlying Fontan-Associated Liver Disease (FALD)
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner Quandary Peak
7:30–10:00 PM Poster Session 2 Quandary Peak
Thursday, March 4, 2027
7:00–8:00 AM Breakfast Quandary Peak
8:00–11:00 AM Weight Loss and Exercise in MASLD Progression Grays Peak
  Samuel Klein, Washington University School of Medicine
Metabolic and Hepatic Implications of Weight Loss
 
  Juleen R. Zierath, Karolinska Institutet
Exercise Medicine for MASLD
 
  Amalia Gastaldelli, Institute of Clinical Physiology, CNR
Linking Glucose Metabolism to MASLD Progression
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:00–2:30 PM On Own for Lunch
2:30–4:30 PM Symposia Spotlight 2 Grays Peak
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–6:15 PM Role of Peripheral Organs in Chronic Liver Disease Progression Grays Peak
  Caterina Conte, San Raffaele Roma University, Rome, Italy
Sarcopenia in Obesity and MASLD: Definition and Clinical Implications
 
  Saswata Talukdar, Roche
Effect of Myostatin and Activin Inhibition on Muscle Mass, Strength and Function
 
  Short Talk(s) Chosen from Abstracts
 
6:15–7:05 PM Closing Keynote Address Grays Peak
  Jens C. Brüning, Max Planck Institute for Metabolism Research
Role of Hypothalamus in MASLD
 
7:05–7:15 PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) Grays Peak
7:15–8:15 PM Social Hour with Dinner Quandary Peak
8:00–9:00 PM Entertainment Quandary Peak
8:00–9:00 PM Cash Bar Quandary Peak
Friday, March 5, 2027
12:00–11:59 PM Departure